Mark S. Forman - 18 Apr 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Medical Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
18 Apr 2022
Transactions value $
$0
Form type
4
Date filed
20 Apr 2022, 16:22
Previous filing
08 Apr 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Options (right to buy) Award $0 +136K $0.00 136K 18 Apr 2022 Common Stock 136K $2.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on April 18, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.